Definition, assessment and treatment of cognitive impairment associated with schizophrenia: expert opinion and practical recommendations
Frontiers in Psychiatry · 20.09.2024 · 15
DOI: 10.3389/fpsyt.2024.1451832 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Psychiatry, online erschienen am 20.09.2024. Verfasst von Antonio Vita und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 234 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
A considerable proportion of patients with schizophrenia perform below population norms on standardized neuropsychological tests, and the performance of those performing within normal range is lower than predicted based on parental education. Cognitive impairment predates the onset of psychosis, is observed during symptom remission and in non-affected first-degree relatives of patients. At the present time, cognitive deficits are regarded as key features of schizophrenia, important determinants of poor psychosocial outcome and targets for both pharmacological and non-pharmacological treatment strategies. A group of eight key opinion leaders reviewed and discussed latest advances in scientific research and current good clinical practices on assessment, management, and treatment of CIAS. In the present paper they summarize the current evidence, identify main gaps between current knowledge and mental health services clinical practice, and provide practical recommendations to reduce the gap.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
- Department of Mental Health and Addiction Services, Azienda Socio-Sanitaria Territoriale (ASST) Spedali Civili of, Brescia, Italy.
- Department of Clinical Neurosciences, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) San Raffaele Scientific Institute, Milan, Italy.
- School of Medicine, Vita-Salute San Raffaele University, Milan, Italy.
- Department of Mental and Physical Health and Preventive Medicine, University of Campania Luigi Vanvitelli, Naples, Italy.
- Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy.
Zitieren
APA
Vita, A., Barlati, S., Cavallaro, R., Mucci, A., Riva, M. A., Rocca, P., Rossi, A., & Galderisi, S. (2024). Definition, assessment and treatment of cognitive impairment associated with schizophrenia: expert opinion and practical recommendations. Frontiers in Psychiatry, 15. https://doi.org/10.3389/fpsyt.2024.1451832
Vancouver
Vita A, Barlati S, Cavallaro R, Mucci A, Riva MA, Rocca P, et al. Definition, assessment and treatment of cognitive impairment associated with schizophrenia: expert opinion and practical recommendations. Frontiers in Psychiatry. 2024;15. doi:10.3389/fpsyt.2024.1451832
BibTeX
@article{Vita2024,
author = {Vita, Antonio and Barlati, Stefano and Cavallaro, Roberto and Mucci, Armida and Riva, Marco A and Rocca, Paola and Rossi, Alessandro and Galderisi, Silvana},
title = {Definition, assessment and treatment of cognitive impairment associated with schizophrenia: expert opinion and practical recommendations},
journal = {Frontiers in Psychiatry},
year = {2024},
volume = {15},
doi = {10.3389/fpsyt.2024.1451832}
}
EUVIMED